Aclaris Therapeutics (ACRS) Accumulated Expenses (2014 - 2026)
Aclaris Therapeutics' Accumulated Expenses came in at $5.96 million for Q2 2026, down 47.8% from $11.41 million a year earlier but up 1.1% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Accumulated Expenses (2014 - 2026) Analysis & Trends
At the end of FY2025, Aclaris Therapeutics' Accumulated Expenses was $8.79 million, down 56.8% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of 8.3% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $20.33 million in FY2024 (+4.6%), $19.45 million in FY2023 (+123.5%), $8.7 million in FY2022 (-13.4%) and $10.05 million in FY2021 (+70.2%).
- The five-year range for quarterly Accumulated Expenses is $4.72 million (Q3 2024) to $20.33 million (Q4 2024).
- Year-over-year, Accumulated Expenses has declined for three consecutive quarters, with growth averaging 4.5% over the last eight quarters.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q4 2023 (growth of 123.5%), and the weakest in Q3 2024 (a decline of 68.9%).
- Business Quant data shows ACRS's Accumulated Expenses at $5.9 million (Q1 2026), $8.79 million (Q4 2025) and $9.78 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Aclaris Therapeutics | 735.48 Mn | 735.48 Mn | 1.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.96 Mn |
| Mar 31, 2026 | 5.90 Mn |
| Dec 31, 2025 | 8.79 Mn |
| Sep 30, 2025 | 9.78 Mn |
| Jun 30, 2025 | 11.41 Mn |
| Mar 31, 2025 | 8.57 Mn |
| Dec 31, 2024 | 20.33 Mn |
| Sep 30, 2024 | 4.72 Mn |
| Jun 30, 2024 | 5.76 Mn |
| Mar 31, 2024 | 6.57 Mn |
| Dec 31, 2023 | 19.45 Mn |
| Sep 30, 2023 | 15.16 Mn |
| Jun 30, 2023 | 8.74 Mn |
| Mar 31, 2023 | 7.26 Mn |
| Dec 31, 2022 | 8.70 Mn |
| Sep 30, 2022 | 9.15 Mn |
| Jun 30, 2022 | 7.57 Mn |
| Mar 31, 2022 | 5.69 Mn |
| Dec 31, 2021 | 10.05 Mn |
| Sep 30, 2021 | 7.41 Mn |
API Access
Aclaris Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();